Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
grad-cov2 (2 trials)
ad6nsmut (3 trials)
adch3nsmut1 (5 trials)
chad3-hlinsmut (1 trial)
mva-hlinsmut (1 trial)
mva-nsmut (4 trials)
mva-rsv (1 trial)
panad3-rsv (1 trial)
Communicable Diseases (Phase 1)
Hepatitis (Phase 1)
Hepatitis A (Phase 1)
Hepatitis C (Phase 1)
Infections (Phase 1)
Respiratory Syncytial Virus Infections (Phase 1)
Virus Diseases (Phase 1)
Trials (10 total)
Trial APIs (8 total)